Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/JPRN-UMIN000030169
JPRN-UMIN000030169Completed未知

Persistence rate of out-patients visit in glaucoma patients - Persistence rate of out-patients visit in glaucoma patients

Santen Pharmaceutical Co., Ltd.0 sites156 target enrollmentStarted: November 30, 2017Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
156
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

The glaucoma patient visit persistence support system has proven to be effective in maintaining the persistence of the patients visits for newly diagnosed glaucoma. Intraocular pressure after the implementation of this support system was significantly lower than at the time of the first visit, suggesting the usefulness of this system for the treatment of glaucoma. (Ganka. 2020,62(8),801-807)

Study Design

Study Type
Observational

Eligibility Criteria

Ages
ot applicable to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •Not applicable

Investigators

Similar Trials

Completed
Not Applicable
Persistence rate of out-patients visit in glaucoma patients (Collect additional data)Glaucoma
JPRN-UMIN000037770Santen Pharmaceutical Co., Ltd.28
Terminated
Not Applicable
Persistence of Glaucoma Patients With Web-Browser-Based Visual Field TestGlaucoma
NCT05690152Andrew Pouw, MD8
Unknown
Not Applicable
Evaluation of Adherence to Clinical Treatment of GlaucomaDrugs Glaucoma
NCT03338088Instituto de Olhos de Goiania150
Completed
Not Applicable
Adherence Improvement in Glaucoma PatientsGlaucoma
NCT00603005Maastricht University Medical Center802
Completed
Not Applicable
Adherence improvement in glaucoma patientsGlaucoma10018307ocular hypertension
NL-OMON31300Alcon Laboratories1,000